Current clinical brain tumor imaging

JE Villanueva-Meyer, MC Mabray, S Cha - Neurosurgery, 2017 - journals.lww.com
Neuroimaging plays an ever evolving role in the diagnosis, treatment planning, and post-
therapy assessment of brain tumors. This review provides an overview of current magnetic …

Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches

M Zhou, J Scott, B Chaudhury, L Hall… - American Journal …, 2018 - Am Soc Neuroradiology
Radiomics describes a broad set of computational methods that extract quantitative features
from radiographic images. The resulting features can be used to inform imaging diagnosis …

Pseudoprogression of brain tumors

SC Thust, MJ van den Bent… - Journal of Magnetic …, 2018 - Wiley Online Library
This review describes the definition, incidence, clinical implications, and magnetic
resonance imaging (MRI) findings of pseudoprogression of brain tumors, in particular, but …

Emerging applications of artificial intelligence in neuro-oncology

JD Rudie, AM Rauschecker, RN Bryan, C Davatzikos… - Radiology, 2019 - pubs.rsna.org
Due to the exponential growth of computational algorithms, artificial intelligence (AI)
methods are poised to improve the precision of diagnostic and therapeutic methods in …

Incorporating diffusion-and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients

JY Kim, JE Park, Y Jo, WH Shim, SJ Nam… - Neuro …, 2019 - academic.oup.com
Background Pseudoprogression is a diagnostic challenge in early posttreatment
glioblastoma. We therefore developed and validated a radiomics model using …

Diffusion-weighted imaging in oncology: an update

C Messina, R Bignone, A Bruno, A Bruno, F Bruno… - Cancers, 2020 - mdpi.com
To date, diffusion weighted imaging (DWI) is included in routine magnetic resonance
imaging (MRI) protocols for several cancers. The real additive role of DWI lies in the …

Imaging glioblastoma posttreatment: progression, pseudoprogression, pseudoresponse, radiation necrosis

SB Strauss, A Meng, EJ Ebani… - Neuroimaging …, 2021 - neuroimaging.theclinics.com
Eighty percent of all malignant primary brain tumors diagnosed in the United States are
gliomas. 1 The current treatment paradigm for high-grade gliomas (grades III and IV) …

Applying amide proton transfer‐weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas

BO Ma, JO Blakeley, X Hong, H Zhang… - Journal of Magnetic …, 2016 - Wiley Online Library
Purpose To assess amide proton transfer‐weighted (APTW) imaging features in patients
with malignant gliomas after chemoradiation and the diagnostic performance of APT …

Incidence of tumour progression and pseudoprogression in high-grade gliomas: a systematic review and meta-analysis

AW Abbasi, HE Westerlaan, GA Holtman… - Clinical …, 2018 - Springer
Background High-grade gliomas are the most common primary brain tumours.
Pseudoprogression describes the false appearance of radiation-induced progression on …

Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic …

AJ Prager, N Martinez, K Beal… - American Journal …, 2015 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Treatment-related changes and recurrent tumors often
have overlapping features on conventional MR imaging. The purpose of this study was to …